{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:17:05Z","timestamp":1787318225775,"version":"build-2736575974"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T00:00:00Z","timestamp":1508198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0185976","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T13:39:06Z","timestamp":1508247546000},"page":"e0185976","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2233-2789","authenticated-orcid":true,"given":"Tomohiro","family":"Makino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Terakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Muneoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Nagahira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Nagane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoji","family":"Yamate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiaki","family":"Utsugisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,10,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00415-015-7963-5","article-title":"Myasthenia gravis: a clinical-immunological update","volume":"263","author":"S Binks","year":"2016","journal-title":"J Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myasthenia Gravis: paradox versus paradigm in autoimmunity","volume":"52","author":"S Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"S Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"JJ Verschuuren","year":"2013","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/joim.12163","article-title":"Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis","volume":"275","author":"MG Huijbers","year":"2014","journal-title":"J Intern Med"},{"key":"ref6","article-title":"Myasthenia gravis\u2014autoantibody characteristics and their implications for therapy","author":"NE Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-510X(02)00200-9","article-title":"The role of antibodies in myasthenia gravis","volume":"202","author":"M De Baets","year":"2002","journal-title":"J Neurol Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e108327","DOI":"10.1371\/journal.pone.0108327","article-title":"Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients","volume":"9","author":"G Kordas","year":"2014","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"EX Albuquerque","year":"2009","journal-title":"Physiol Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4A resolution","volume":"346","author":"N Unwin","year":"2005","journal-title":"J Mol Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.158.4.1919","article-title":"Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies","volume":"158","author":"YF Graus","year":"1997","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"13898","DOI":"10.1523\/JNEUROSCI.2833-09.2009","article-title":"Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity","volume":"29","author":"J Luo","year":"2009","journal-title":"J Neurosci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(87)90092-0","article-title":"Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor","volume":"15","author":"S Tzartos","year":"1987","journal-title":"J Neuroimmunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(99)00259-3","article-title":"Prevention of passively transferred experimental autoimmune myasthenia gravis by Fab fragments of monoclonal antibodies directed against the main immunogenic region of the acetylcholine receptor","volume":"104","author":"D Papanastasiou","year":"2000","journal-title":"J Neuroimmunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/eji.200425671","article-title":"Isolation of potent human Fab fragments against a novel highly immunogenic region on human muscle acetylcholine receptor which protect the receptor from myasthenic autoantibodies","volume":"35","author":"E Fostieri","year":"2005","journal-title":"Eur J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/eji.200526173","article-title":"Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci","volume":"35","author":"E Protopapadakis","year":"2005","journal-title":"Eur J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/clim.2000.4898","article-title":"Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries","volume":"96","author":"E Rey","year":"2000","journal-title":"Clin Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2013.12.008","article-title":"Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor","volume":"52","author":"K Vrolix","year":"2014","journal-title":"J Autoimmun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrd.2015.16","article-title":"Single-cell analysis tools for drug discovery and development","volume":"15","author":"JR Heath","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrg3833","article-title":"Computational and analytical challenges in single-cell transcriptomics","volume":"16","author":"O Stegle","year":"2015","journal-title":"Nat Rev Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1243259","DOI":"10.1126\/science.1243259","article-title":"Single-cell metabolomics: analytical and biological perspectives","volume":"342","author":"R Zenobi","year":"2013","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nbt.2782","article-title":"The promise and challenge of high-throughput sequencing of the antibody repertoire","volume":"32","author":"G Georgiou","year":"2014","journal-title":"Nat Biotechnol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/imm.12553","article-title":"Single-cell technologies to study the immune system","volume":"147","author":"V Proserpio","year":"2016","journal-title":"Immunology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coi.2015.06.009","article-title":"Serology in the 21st century: the molecular-level analysis of the serum antibody repertoire","volume":"35","author":"Y Wine","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1966","article-title":"A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood","volume":"15","author":"A Jin","year":"2009","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/1087057114564760","article-title":"A fully automated primary screening system for the discovery of therapeutic antibodies directly from B cells","volume":"20","author":"S Tickle","year":"2015","journal-title":"J Biomol Screen"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1741-7007-10-80","article-title":"Rapid production of antigen-specific monoclonal antibodies from a variety of animals","volume":"10","author":"N Kurosawa","year":"2012","journal-title":"BMC Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1472-6750-11-75","article-title":"Target-selective joint polymerase chain reaction: a robust and rapid method for high-throughput production of recombinant monoclonal antibodies from single cells","volume":"11","author":"M Yoshioka","year":"2011","journal-title":"BMC Biotechnol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1523\/JNEUROSCI.09-03-01082.1989","article-title":"A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671","volume":"9","author":"MA Luther","year":"1989","journal-title":"J Neurosci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/clinchem\/45.3.400","article-title":"TE671 cell-based ELISA for anti-acetylcholine receptor antibody determination in myasthenia gravis","volume":"45","author":"D Franciotta","year":"1999","journal-title":"Clin Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1309\/AJCPYEOR6SGE8ZLU","article-title":"Detection of acetylcholine receptor modulating antibodies by flow cytometry","volume":"143","author":"BK Lozier","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(96)12488-5","article-title":"Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the epsilon subunit","volume":"207","author":"D Beeson","year":"1996","journal-title":"Neurosci Lett"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.188.9.1679","article-title":"Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells","volume":"188","author":"U Klein","year":"1998","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1126\/science.1201730","article-title":"Different B cell populations mediate early and late memory during an endogenous immune response","volume":"331","author":"KA Pape","year":"2011","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nm.3743","article-title":"In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire","volume":"21","author":"BJ DeKosky","year":"2015","journal-title":"Nat Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e83036","DOI":"10.1371\/journal.pone.0083036","article-title":"Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica","volume":"8","author":"N Chihara","year":"2013","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1073\/pnas.1317793111","article-title":"Identification and characterization of the constituent human serum antibodies elicited by vaccination","volume":"111","author":"JJ Lavinder","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/mus.24057","article-title":"Targeting therapy to the neuromuscular junction: proof of concept","volume":"49","author":"LL Kusner","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"12613","DOI":"10.1074\/jbc.M108845200","article-title":"Yeast expression and NMR analysis of the extracellular domain of muscle nicotinic acetylcholine receptor alpha subunit","volume":"277","author":"Y Yao","year":"2002","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"26980","DOI":"10.1074\/jbc.M110731200","article-title":"Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding","volume":"277","author":"L Psaridi-Linardaki","year":"2002","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/adt.2009.9996","article-title":"AlphaLISA immunoassay platform- the "no-wash" high-throughput alternative to ELISA","volume":"7","author":"M Bielefeld-Sevigny","year":"2009","journal-title":"Assay Drug Dev Technol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.neuint.2010.01.011","article-title":"Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel","volume":"56","author":"HR Arias","year":"2010","journal-title":"Neurochem Int"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1073\/pnas.0630641100","article-title":"Membrane potential fluorescence: a rapid and highly sensitive assay for nicotinic receptor channel function","volume":"100","author":"RW Fitch","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"VA Lennon","year":"1975","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jneuroim.2013.09.006","article-title":"Disturbed B cell subpopulations and increased plasma cells in myasthenia gravis patients","volume":"264","author":"S Kohler","year":"2013","journal-title":"J Neuroimmunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e23532","DOI":"10.1371\/journal.pone.0023532","article-title":"Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting","volume":"6","author":"L Morris","year":"2011","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/19420862.2015.1109757","article-title":"Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures","volume":"8","author":"KS Cox","year":"2016","journal-title":"MAbs"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jmb.2006.02.040","article-title":"Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing","volume":"358","author":"PJ Meijer","year":"2006","journal-title":"J Mol Biol"},{"key":"ref49","first-page":"1","article-title":"Clinical immunology","author":"DW CJ Andrew","year":"1980"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1196\/annals.1405.007","article-title":"Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains","volume":"1132","author":"J Lindstrom","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0896-6273(95)90037-3","article-title":"Three-dimensional location of the main immunogenic region of the acetylcholine receptor","volume":"15","author":"R Beroukhim","year":"1995","journal-title":"Neuron"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/clinchem\/42.9.1518","article-title":"Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method","volume":"42","author":"EF Ullman","year":"1996","journal-title":"Clin Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","article-title":") Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities","volume":"13","author":"JL Xu","year":"2000","journal-title":"Immunity"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/jnnp-2012-302705","article-title":"Antibodies against the main immunogenic region of the acetylcholine receptor correlate with disease severity in myasthenia gravis","volume":"83","author":"T Masuda","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.expneurol.2015.03.010","article-title":"Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors\u2014Recommendations for methods and experimental designs","volume":"270","author":"M Losen","year":"2015","journal-title":"Exp Neurol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/HAB-2009-0196","article-title":"Three decades of human monoclonal antibodies: past, present and future developments","volume":"18","author":"M Steinitz","year":"2009","journal-title":"Hum Antibodies"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4161\/mabs.12187","article-title":"Mining human antibody repertoires","volume":"2","author":"RR Beerli","year":"2010","journal-title":"MAbs"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nbt1126","article-title":"Selecting and screening recombinant antibody libraries","volume":"23","author":"HR Hoogenboom","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2012.06766.x","article-title":"Myasthenogenicity of the main immunogenic region","volume":"1274","author":"J Lindstrom","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1212\/WNL.36.5.612","article-title":"Myasthenia gravis: monoclonal antihuman acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatment","volume":"36","author":"PJ Whiting","year":"1986","journal-title":"Neurology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized Trial of Thymectomy in Myasthenia Gravis","volume":"375","author":"GI Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/acn3.314","article-title":"Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up","volume":"3","author":"D Anderson","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"D Grob","year":"2008","journal-title":"Muscle Nerve"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-065X.1998.tb01217.x","article-title":"Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis","volume":"164","author":"A Vincent","year":"1998","journal-title":"Immunol Rev"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1172\/JCI44425","article-title":"Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity","volume":"120","author":"J Yamagami","year":"2010","journal-title":"J Clin Invest"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ana.22657","article-title":"Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica","volume":"71","author":"L Tradtrantip","year":"2012","journal-title":"Ann Neurol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41598-017-01019-5","article-title":"Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys","volume":"7","author":"M Losen","year":"2017","journal-title":"Sci Rep"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molimm.2014.01.002","article-title":"Design, synthesis, and characterization of a 39 amino acid peptide mimic of the main immunogenic region of the Torpedo acetylcholine receptor","volume":"59","author":"VB Trinh","year":"2014","journal-title":"Mol Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0185976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T03:53:42Z","timestamp":1693108422000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0185976"}},"subtitle":[],"editor":[{"given":"G\u00fcher","family":"Saruhan-Direskeneli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,17]]},"references-count":68,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0185976","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,17]]}}}